IV 
118TH CONGRESS 
2D SESSION 
H. RES. 1595 
Expressing support for the designation of November 2024 as ‘‘National Lung 
Cancer Awareness Month’’ and expressing support for early detection 
and treatment of lung cancer. 
IN THE HOUSE OF REPRESENTATIVES 
NOVEMBER 22, 2024 
Mr. BOYLE of Pennsylvania (for himself, Mr. AUCHINCLOSS, and Mr. 
LAWLER) submitted the following resolution; which was referred to the 
Committee on Energy and Commerce 
RESOLUTION 
Expressing support for the designation of November 2024 
as ‘‘National Lung Cancer Awareness Month’’ and ex-
pressing support for early detection and treatment of 
lung cancer. 
Whereas lung cancer is the leading cause of cancer-related 
death among individuals in the United States, accounting 
for more deaths than colon cancer, breast cancer, and 
prostate cancer combined; 
Whereas, in 2024, an estimated 234,580 individuals in the 
United States will be diagnosed with lung cancer, and 
125,070 individuals (approximately 340 individuals per 
day) will die from the disease; 
VerDate Sep 11 2014 
01:41 Nov 23, 2024
Jkt 059200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6300
E:\BILLS\HR1595.IH
HR1595
kjohnson on DSK7ZCZBW3PROD with $$_JOB
•HRES 1595 IH 
Whereas 1 in 16 men and 1 in 17 women in the United 
States will develop lung cancer during their lifetimes; 
Whereas the rate of lung cancer death in women in the 
United States has increased by 92 percent over the 50- 
year span from 1971 to 2021; 
Whereas, each year, more women die from lung cancer than 
breast cancer and ovarian cancer combined; 
Whereas women who never smoked are more than twice as 
likely to get lung cancer as men who never smoked; 
Whereas, in 2024, 20,300 people will die from lung cancer 
unrelated to smoking, which would be the eighth-leading 
cause of cancer death if classified as a separate disease; 
Whereas, approximately 10 to 20 percent of lung cancers 
occur in people who are nonsmokers, and the proportion 
of lung cancers diagnosed in individuals who have never 
smoked is increasing in the United States; 
Whereas, in 2024, approximately 101,300 of the 125,070 
lung cancer deaths (81 percent) will be caused by ciga-
rette smoking directly, and secondhand smoke causes 
over 7,300 lung cancer deaths each year in adults who 
do not smoke; 
Whereas the 5-year survival rate is 65 percent for those diag-
nosed with localized lung cancer and 9 percent for those 
diagnosed at a stage when the cancer has spread to dis-
tant parts of the body; 
Whereas screening with low-dose computed tomography can 
detect lung cancer in its earliest stages and ultimately 
save lives, yet only 5.8 percent of individuals in the 
United States at high risk for lung cancer undergo lung 
cancer screening; 
VerDate Sep 11 2014 
03:49 Nov 23, 2024
Jkt 059200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6300
E:\BILLS\HR1595.IH
HR1595
kjohnson on DSK7ZCZBW3PROD with $$_JOB
•HRES 1595 IH 
Whereas geographic availability of facilities and transpor-
tation barriers are persistent challenges to lung cancer 
screening; 
Whereas nearly 70 percent of adults are not familiar with 
lung cancer screening and the low-dose computed tomog-
raphy scan; 
Whereas lung cancer is the second most commonly diagnosed 
cancer in veterans; 
Whereas veterans are 25 percent more likely to develop lung 
cancer compared to the general public, and, although ap-
proximately 1,000,000 to 2,000,000 veterans have an ele-
vated risk of lung cancer and are eligible for screening, 
less than 3 percent of veterans get screened; 
Whereas Black men have the highest incidence of lung cancer 
and the highest mortality rate from lung cancer in the 
United States, and nonwhite individuals are 14 to 17 
percent less likely to be diagnosed with lung cancer early; 
Whereas changes made to the United States Preventive Serv-
ices Task Force lung cancer screening guidelines in 2021 
increased the number of individuals in the United States 
who are recommended to receive screening from 
8,000,000 to 14,500,000; 
Whereas the stigma surrounding lung cancer— 
(1) creates barriers to early diagnosis, treatment, 
and research; 
(2) has a detrimental impact on the quality of life 
of lung cancer patients; and 
(3) hinders funding into lung cancer risk factors un-
related to smoking; 
Whereas lung cancer research is leading to breakthroughs in 
biomarker 
identification 
and 
the 
development 
of 
VerDate Sep 11 2014 
01:41 Nov 23, 2024
Jkt 059200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6300
E:\BILLS\HR1595.IH
HR1595
kjohnson on DSK7ZCZBW3PROD with $$_JOB
•HRES 1595 IH 
immunotherapies and targeted therapies that are highly 
effective for some cancer subtypes, yet accessing cutting 
edge testing as part of the lung cancer diagnostic process 
can be difficult; and 
Whereas educational efforts can increase awareness of lung 
cancer and lung cancer screening among the general pub-
lic, patients and their families, and health care workers, 
thereby increasing the early detection of lung cancer: 
Now, therefore, be it 
Resolved, That the House of Representatives— 
(1) expresses support for the designation of 
‘‘National Lung Cancer Awareness Month’’; 
(2) supports the purposes and ideals of Na-
tional Lung Cancer Awareness Month; 
(3) promotes efforts to increase awareness of, 
education about, and research on— 
(A) mitigation of risk factors; 
(B) lung cancer screening; 
(C) treatment of lung cancer; and 
(D) lung cancer affecting minorities and 
individuals who have never smoked; and 
(4) encourages the people of the United States 
to observe National Lung Cancer Awareness Month 
with appropriate awareness and educational activi-
ties. 
Æ 
VerDate Sep 11 2014 
01:41 Nov 23, 2024
Jkt 059200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6301
E:\BILLS\HR1595.IH
HR1595
kjohnson on DSK7ZCZBW3PROD with $$_JOB